• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生活方式与非肌层浸润性膀胱癌的复发、进展及死亡率:现有研究与未来方向

Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions.

作者信息

Zuniga Kyle B, Graff Rebecca E, Feiger David B, Meng Maxwell V, Porten Sima P, Kenfield Stacey A

机构信息

Department of Urology, University of California, San Francisco, CA, USA.

Osher Center for Integrative Medicine, University of California, San Francisco, CA, USA.

出版信息

Bladder Cancer. 2020;6(1):9-23. doi: 10.3233/blc-190249. Epub 2020 Mar 28.

DOI:10.3233/blc-190249
PMID:34095407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8174672/
Abstract

BACKGROUND

A broad, comprehensive review of studies exploring associations between lifestyle factors and non-muscle invasive bladder cancer (NMIBC) outcomes is warranted to consolidate recommendations and identify gaps in research.

OBJECTIVE

To summarize the literature on associations between lifestyle factors and clinical outcomes among patients with NMIBC.

METHODS

PubMed was systematically queried for articles published through March 2019 regarding lifestyle factors and recurrence, progression, cancer-specific mortality, and all-cause mortality among patients with NMIBC.

RESULTS

Notwithstanding many ambiguities, there is good-quality evidence suggesting a benefit of smoking avoidance/cessation, healthy body mass index (BMI), and type II diabetes mellitus prevention and treatment. probiotic supplementation may reduce recurrence. There have been individual studies suggesting a benefit for uncooked broccoli and supplemental vitamin E as well as avoidance of supplemental vitamin B9, areca nut chewing, and a "Western diet" pattern high in fried foods and red meat. Additional studies do not suggest associations between NMIBC outcomes and use of fibrin clot inhibitors; insulin and other oral hypoglycemics; statins; supplemental selenium, vitamin A, vitamin C, and vitamin B6; fluid intake and intake of specific beverages (e.g., alcohol, coffee, green tea, cola); various dietary patterns (e.g., Tex-Mex, high fruit and vegetable, low-fat); and occupational and chemical exposures.

CONCLUSIONS

Despite a myriad of publications on lifestyle factors and NMIBC, a need remains for research on unexplored associations (e.g., physical activity) and further studies that can elucidate causal effects. This would inform future implementation strategies for healthy lifestyle change in NMIBC patients.

摘要

背景

有必要对探索生活方式因素与非肌层浸润性膀胱癌(NMIBC)预后之间关联的研究进行广泛、全面的综述,以整合建议并找出研究中的差距。

目的

总结关于生活方式因素与NMIBC患者临床预后之间关联的文献。

方法

系统检索PubMed,查找截至2019年3月发表的有关NMIBC患者生活方式因素与复发、进展、癌症特异性死亡率和全因死亡率的文章。

结果

尽管存在许多不明确之处,但有高质量证据表明避免吸烟/戒烟、保持健康的体重指数(BMI)以及预防和治疗2型糖尿病有益。补充益生菌可能会降低复发率。有个别研究表明,生西兰花和补充维生素E有益,同时应避免补充维生素B9、嚼槟榔以及避免“西方饮食”模式(即富含油炸食品和红肉)。其他研究未表明NMIBC预后与使用纤维蛋白凝块抑制剂、胰岛素和其他口服降糖药、他汀类药物、补充硒、维生素A、维生素C和维生素B6、液体摄入量以及特定饮料(如酒精、咖啡、绿茶、可乐)的摄入量、各种饮食模式(如德克萨斯-墨西哥饮食、高果蔬饮食、低脂饮食)以及职业和化学暴露之间存在关联。

结论

尽管有大量关于生活方式因素与NMIBC的出版物,但仍需要对未探索的关联(如体育活动)进行研究,并开展进一步研究以阐明因果效应。这将为未来NMIBC患者健康生活方式改变的实施策略提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d237/8174672/1cf059af9232/nihms-1583231-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d237/8174672/1cf059af9232/nihms-1583231-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d237/8174672/1cf059af9232/nihms-1583231-f0001.jpg

相似文献

1
Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions.生活方式与非肌层浸润性膀胱癌的复发、进展及死亡率:现有研究与未来方向
Bladder Cancer. 2020;6(1):9-23. doi: 10.3233/blc-190249. Epub 2020 Mar 28.
2
Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis.体重指数、饮食相关因素与膀胱癌预后:一项系统评价与Meta分析
Bladder Cancer. 2018 Jan 20;4(1):91-112. doi: 10.3233/BLC-170147.
3
Low awareness, adherence, and practice but positive attitudes regarding lifestyle recommendations among non-muscle-invasive bladder cancer patients.非肌层浸润性膀胱癌患者对生活方式建议的认知、依从性和实践水平较低,但态度积极。
Urol Oncol. 2019 Sep;37(9):573.e1-573.e8. doi: 10.1016/j.urolonc.2019.04.016. Epub 2019 May 8.
4
Effect of smoking on the recurrence and progression of non-muscle-invasive bladder cancer.吸烟对非肌层浸润性膀胱癌复发和进展的影响。
Clin Transl Oncol. 2025 Apr;27(4):1695-1711. doi: 10.1007/s12094-024-03694-z. Epub 2024 Sep 12.
5
The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer.吸烟及戒烟时间对非肌层浸润性膀胱癌临床结局的影响。
Urol Oncol. 2015 Feb;33(2):65.e9-17. doi: 10.1016/j.urolonc.2014.06.002. Epub 2014 Jul 9.
6
Diet and lifestyle considerations for patients with prostate cancer.前列腺癌患者的饮食和生活方式注意事项。
Urol Oncol. 2020 Mar;38(3):105-117. doi: 10.1016/j.urolonc.2019.06.018. Epub 2019 Jul 18.
7
Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer.饮食模式与非肌肉浸润性膀胱癌复发和进展的风险。
Int J Cancer. 2018 May 1;142(9):1797-1804. doi: 10.1002/ijc.31214. Epub 2017 Dec 26.
8
The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer.“保持健康”研究:一项关于生活方式和遗传因素以降低非肌层浸润性膀胱癌复发和进展风险的前瞻性队列研究。
Cancer Causes Control. 2019 Feb;30(2):187-193. doi: 10.1007/s10552-019-1130-8. Epub 2019 Jan 17.
9
The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life.UroLife研究:一项关于生活方式习惯与非肌层浸润性膀胱癌预后及健康相关生活质量关系的荷兰前瞻性队列研究方案。
BMJ Open. 2019 Oct 16;9(10):e030396. doi: 10.1136/bmjopen-2019-030396.
10
Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle.预防膀胱癌的发生和复发:营养与生活方式
Curr Opin Urol. 2018 Jan;28(1):88-92. doi: 10.1097/MOU.0000000000000452.

引用本文的文献

1
Nuclear Receptors in Bladder Cancer: Insights into miRNA-Mediated Regulation and Potential Therapeutic Implications.膀胱癌中的核受体:对miRNA介导的调控及潜在治疗意义的见解
Int J Mol Sci. 2025 Jul 29;26(15):7340. doi: 10.3390/ijms26157340.
2
Prediction of recurrence risk in patients with non-muscle-invasive bladder cancer.非肌层浸润性膀胱癌患者复发风险的预测
Asian J Urol. 2024 Oct;11(4):625-632. doi: 10.1016/j.ajur.2023.04.007. Epub 2024 Feb 23.
3
Deciphering the molecular heterogeneity of intermediate- and (very-)high-risk non-muscle-invasive bladder cancer using multi-layered studies.

本文引用的文献

1
Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial.自我监测和提醒短信以增加结直肠癌幸存者的身体活动(Smart Pace):一项试点随机对照试验。
BMC Cancer. 2019 Mar 11;19(1):218. doi: 10.1186/s12885-019-5427-5.
2
Does the Diagnosis of Bladder Cancer Lead to Higher Rates of Smoking Cessation? Findings from the Medicare Health Outcomes Survey.膀胱癌的诊断是否会导致更高的戒烟率?来自 Medicare 健康结果调查的发现。
J Urol. 2019 Aug;202(2):241-246. doi: 10.1097/JU.0000000000000206. Epub 2019 Jul 8.
3
The Microbiome and Genitourinary Cancer: A Collaborative Review.
运用多层次研究解析中高危和(极)高危非肌层浸润性膀胱癌的分子异质性
Front Oncol. 2024 Oct 21;14:1424293. doi: 10.3389/fonc.2024.1424293. eCollection 2024.
4
Microbiome and bladder cancer: the role of probiotics in treatment.微生物群与膀胱癌:益生菌在治疗中的作用
Future Microbiol. 2025 Jan;20(1):73-90. doi: 10.1080/17460913.2024.2414671. Epub 2024 Oct 24.
5
An Association Study of Germline Variants in Bladder Cancer-Related Genes with the Prognosis of Non-Muscle Invasive Bladder Cancer.膀胱癌相关基因种系变异与非肌层浸润性膀胱癌预后的关联研究
Bladder Cancer. 2023 Mar 31;9(1):59-71. doi: 10.3233/BLC-220076. eCollection 2023.
6
Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs.中高危非肌层浸润性膀胱癌:流行病学、疾病负担及未满足需求概述
Front Oncol. 2023 Jun 2;13:1170124. doi: 10.3389/fonc.2023.1170124. eCollection 2023.
7
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice.膀胱癌流行病学的全球趋势:公共卫生和临床实践面临的挑战。
Nat Rev Clin Oncol. 2023 May;20(5):287-304. doi: 10.1038/s41571-023-00744-3. Epub 2023 Mar 13.
8
Limited Changes in Lifestyle Behaviours after Non-Muscle Invasive Bladder Cancer Diagnosis.非肌肉浸润性膀胱癌诊断后生活方式行为的有限变化。
Cancers (Basel). 2022 Feb 15;14(4):960. doi: 10.3390/cancers14040960.
9
Bladder cancer and exeRcise trAining during intraVesical thErapy-the BRAVE trial: a study protocol for a prospective, single-centre, phase II randomised controlled trial.膀胱癌与膀胱内治疗期间的运动训练:BRAVE 试验的研究方案——一项前瞻性、单中心、II 期随机对照试验。
BMJ Open. 2021 Sep 24;11(9):e055782. doi: 10.1136/bmjopen-2021-055782.
10
Association between blood pressure and BMI with bladder cancer risk and mortality in 340,000 men in three Swedish cohorts.在三个瑞典队列的 340,000 名男性中,血压和 BMI 与膀胱癌风险和死亡率的关系。
Cancer Med. 2021 Feb;10(4):1431-1438. doi: 10.1002/cam4.3721. Epub 2021 Jan 16.
微生物组与泌尿生殖系统肿瘤:协作综述。
Eur Urol. 2019 Apr;75(4):637-646. doi: 10.1016/j.eururo.2018.12.043. Epub 2019 Jan 15.
4
Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer.一项基于技术增强的行为改变干预措施(前列腺癌 8 号)的可行性、可接受性和行为结果:一项针对前列腺癌男性的试点随机对照试验。
Eur Urol. 2019 Jun;75(6):950-958. doi: 10.1016/j.eururo.2018.12.040. Epub 2019 Jan 10.
5
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
6
Novel application of metformin combined with targeted drugs on anticancer treatment.二甲双胍联合靶向药物在抗肿瘤治疗中的新应用。
Cancer Sci. 2019 Jan;110(1):23-30. doi: 10.1111/cas.13849. Epub 2018 Nov 28.
7
BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004).BOXIT-一项评估塞来昔布联合标准治疗方案用于治疗膀胱移行细胞癌(CRUK/07/004)的随机 III 期安慰剂对照试验。
Eur Urol. 2019 Apr;75(4):593-601. doi: 10.1016/j.eururo.2018.09.020. Epub 2018 Sep 29.
8
Lifestyle Indices and Cardiovascular Disease Risk: A Meta-analysis.生活方式指数与心血管疾病风险:一项荟萃分析。
Am J Prev Med. 2018 Oct;55(4):555-564. doi: 10.1016/j.amepre.2018.04.046.
9
Optimal body mass index cut-point for predicting recurrence-free survival in patients with non-muscle-invasive urothelial carcinoma of bladder.预测非肌层浸润性膀胱尿路上皮癌患者无复发生存的最佳体重指数切点
Oncol Lett. 2018 Sep;16(3):4049-4056. doi: 10.3892/ol.2018.9068. Epub 2018 Jul 4.
10
Total Fluid Intake and the Risk of Recurrence in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study.非肌层浸润性膀胱癌患者的总液体摄入量与复发风险:一项前瞻性队列研究。
Bladder Cancer. 2018 Jul 30;4(3):303-310. doi: 10.3233/BLC-180172.